Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.

Lantern Pharma Inc Is A Biopharmaceutical Company Focused On Developing Oncology Drug Candidates Using Its Artificial Intelligence Platform. The Company Utilizes Its Proprietary Radr Platform To Identify, Develop, And Advance Small Molecule Therapies And Antibody-Drug Conjugates, With A Pipeline That Includes Three Lead Small Molecule Drug Candidates (Lp-300, Lp-184, And Lp-284) Targeting Solid Tumors And Blood Cancers. It Also Advances Programs Through Its Subsidiary Focused On Central Nervous System And Brain Cancers.